Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disorders

Multiple Sclerosis Journal

Volumn 20, Issue 9, 2014, Pages 1189-1197

  Von Glehn, Felipe ^a   Jarius, Sven ^b   Cavalcanti Lira, Rodrigo Pessoa ^a   Alves Ferreira, Maria Carolina ^a   Von Glehn, Fadua H Ribeiro ^a   Costa E Castro, Stella Maris ^a   Beltramini, Guilherme Coco ^a   Bergo, Felipe P ^a   Farias, Alessandro S ^a   Brandão, Carlos Otávio ^a   Wildemann, Brigitte ^b   Damasceno, Benito P ^a   Cendes, Fernando ^a   Santos, Leonilda M B ^a   Yasuda, Clarissa Lin ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

longitudinally extensive transverse myelitis; Neuromyelitis optica; optical coherence tomography analysis; retinal nerve fiber layer atrophy; VBM analysis

Indexed keywords

AQUAPORIN 4;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTE; BRAIN ATROPHY; BRAIN DISEASE; BRAIN STEM; CEREBELLUM; CEREBELLUM CORTEX; CINGULATE SULCUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); CROSS-SECTIONAL STUDY; DIFFUSION TENSOR IMAGING; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; FRONTAL LOBE; GRAY MATTER; HUMAN; HUMAN TISSUE; MALE; MYELOOPTIC NEUROPATHY; NEUROIMAGING; NEUROMYELITIS OPTICA SPECTRUM DISORDER; OCCIPITAL LOBE; OPTIC CHIASM; OPTIC NERVE LESION; OPTICAL COHERENCE TOMOGRAPHY; PARAHIPPOCAMPAL GYRUS; PARIETAL LOBE; RETINAL NERVE FIBER LAYER THICKNESS; TEMPORAL LOBE; THALAMUS; VOXEL BASED MORPHOMETRY; WHITE MATTER; DISEASE ASSOCIATION; CASE CONTROL STUDY; DIAGNOSTIC IMAGING; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; PREDICTIVE VALUE; PROGNOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIFFUSION TENSOR IMAGING; FEMALE; GRAY MATTER; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROMYELITIS OPTICA; OPTIC NERVE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TOMOGRAPHY, OPTICAL COHERENCE; WHITE MATTER; YOUNG ADULT;

EID: 84897935386     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513519838     Document Type: Article

References (37)

1. Wingerchuk DM, Hogancamp WF, O'Brien PC, et al. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999 ; 53: 1107-1114 (Pubitemid 29442132)
2. Jarius S, Ruprecht K, Wildemann B, et al. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflammation. 2012 ; 9: 14
3. Lennon VA, Wingerschuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004 ; 364: 2106-2112 (Pubitemid 39626806)
4. Jarius S, Wildemann B. AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol. 2010 ; 6: 383-392
5. Akman-Demir G, Tüzün E, Waters P, et al. Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients. J Neurol. 2011 ; 258: 464-470
6. Weinshenker BG, Wingerchuk DM, Vukusic S, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol. 2006 ; 59: 566-9 (Pubitemid 43358081)
7. Jarius S, Frederikson J, Waters P, et al. Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis. J Neurol Sci. 2010 ; 298: 158-162
8. Petzold A, Pittock S, Lennon V, et al. Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis. J Neurol Neurosurg Psychiatry. 2010 ; 81: 109-111
9. Wingerchuk DM. Diagnosis and treatment of neuromyelitis optica. Neurologist. 2007 ; 13: 2-11 (Pubitemid 46095579)
10. Popescu BF, Parisi JE, Cabrera-Gómez JA, et al. Absence of cortical demyelination in neuromyelitis optica. Neurology. 2010 ; 75: 2103-2109
11. Calabrese M, Oh MS, Favaretto A, et al. No MRI evidence of cortical lesions in neuromyelitis optica. Neurology. 2012 ; 79: 1671-1676
12. Pichiecchio A, Tavazzi E, Poloni G, et al. Advanced magnetic resonance imaging of neuromyelitis optica: a multiparametric approach. Mult Scler. 2012 ; 18: 817-824
13. Rocca MA, Agosta F, Mezzapesa DM, et al. Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica. Neurology. 2004 ; 62: 476-478 (Pubitemid 38200865)
14. Merle H, Olindo S, Donnio A, et al. Retinal peripapillary nerve fiber layer thickness in neuromyelitis optica. Invest Ophthalmol Vis Sci. 2008 ; 49: 4412-4417
15. De Seze J, Blanc F, Jeanjean L, et al. Optical coherence tomography in neuromyelitis optica. Arch Neurol. 2008 ; 65: 920-923 (Pubitemid 352008475)
16. Green AJ, Cree BA. Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritis. J Neurol Neurosurg Psychiatry. 2009 ; 80: 1002-1005
17. Ratchford JN, Quigg ME, Conger A, et al. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology. 2009 ; 73: 302-308
18. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007 ; 6: 805-815 (Pubitemid 47238676)
19. Von Glehn F, Jarius S, Penalva de Oliveira AC, et al. Aquaporin-4 antibodies are not related to HTLV-1 associated myelopathy. PLoS One. 2012 ; 7 (7). e39372
20. Jarius S, Probst C, Borowski K, et al. Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen. J Neurol Sci. 2010 ; 291: 52-56
21. Bendschneider D, Tornow RP, Horn FK, et al. Retinal nerve fiber layer thickness in normals measured by spectral domain OCT. J Glaucoma. 2010 ; 19: 475-482
22. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage. 2004 ; 23: S208-219
23. Smith SM, Jenkinson M, Johansen-Berg H, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage. 2006 ; 31: 1487-1505
24. Ashburner JA. A fast diffeomorphic image registration algorithm. Neuroimage. 2007 ; 38: 95-113
25. Ashburner J, Friston KJ. Voxel-based morphometry - the methods. NeuroImage. 2000 ; 11: 805-821 (Pubitemid 30437668)
26. Lancaster JL, Woldorff MG, Parsons LM, et al. Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp. 2000 ; 10: 120-131 (Pubitemid 30456920)
27. Fischl B. FreeSurfer. Neuroimage. 2012 ; 62: 774-781
28. Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage. 2002 ; 15: 870-878 (Pubitemid 34852500)
29. Wingerchuk DM. Neuromyelitis optica: effect of gender. J Neurol Sci. 2009 ; 286: 18-23
30. Jarius S, Paul F, Franciotta D, et al. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J Neurol Sci. 2011 ; 306: 82-90
31. Merle H, Olindo S, Bonnan M, et al. Natural history of the visual impairment of relapsing neuromyelitis optica. Ophthalmology. 2007 ; 114: 810-805
32. Kitley J, Leite MI, Nakashima I, et al. Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. Brain. 2012 ; 135: 1834-1849
33. Ciccarelli O. Do cortical lesions help us to distinguish MS from NMO?. Neurology. 2012 ; 79: 1630-1631
34. Yaguchi H, Yabe I, Takai Y, et al. Pathological study of subacute autoimmune encephalopathy with anti-AQP4 antibodies in a pregnant woman. Mult Scler. 2012 ; 18: 683-687
35. Saji E, Arakawa M, Yanagawa K, et al. Cognitive impairment and cortical degeneration in neuromyelitis optica. Ann Neurol. 2013 ; 73: 65-76
36. Gelfand JM, Nolan R, Schwartz DM, et al. Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain. 2012 ; 135: 1786-1793
37. Kaufhold F, Zimmermann H, Schneider E, et al. Optic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosis. PLoS One. 2013 ; 8 (8). e71145